Looks like you’re on the UK site. Choose another location to see content specific to your location

HomeBlog General Current heavy hitters in the clinical micro-market

Current heavy hitters in the clinical micro-market

19th May 2022

Recently, I posted about the current heavy hitters in the clinical micro market – but who’s next up?

Endless innovation generally from the US is progressing into our U.K. / European Market, in the past year, we have seen T2 Biosystems enter a partnership with Werfen.

Below are some great examples of growing organisations based out of the US we could see one day enter the global marketplace.

– Pattern Bioscience led by Nicolas Arab and Ross Johnson has developed an excellent ‘Digital Culture™️’ product that delivers ID and AST Results in unision within four hours.

– Day Zero Diagnostics, Inc have created a new way of diagnosing infectious disease tests using sequencing and computerised learning to combat antibiotic-resistant infectious.

In case you missed the previous blog, here are some of the other major players:

– Bruker • Microbiology & Diagnostics
– bioMérieux
– Hologic, Inc.
– Cepheid
– BD
– QIAGEN

On a recruitment front, microbiology is a forever growing area with excellent innovation that arises YOY, if you are seeking a sales, application or marketing position for an organisation continuously offering market disruptive technology please do reach out to James Higgins.

Placeholder Image

Zenopa offsets an additional 10 tonnes of CO2e through tree planting

Next article

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.